Do bath additives help a child’s eczema?

A large UK trial found no meaningful extra benefit from emollient bath additives. That result does not apply to leave-on moisturisers or every eczema treatment.

Prepared by PoshanSense · AI-assisted educational writing
Our sources and editorial approach · Not clinically reviewed

Research explained · Published 2018

When a child’s skin is uncomfortable, an extra bottle can feel like an extra chance to help. But more steps do not automatically make a care routine more effective. The useful question is whether a product adds something beyond care already being provided.

First, which product are we talking about?

Here, “bath additive” means an emollient formulated to be poured into bath water. It is not the same as a moisturiser left on the skin or an emollient used as a soap substitute. Confusing those categories turns a useful result into an unhelpful claim that all moisturisers fail.

The BATHE trial tested the extra bath product. Both groups continued usual eczema care, including leave-on products and topical treatment when needed. That is the comparison the answer depends on.

Did children become noticeably better?

The main symptom comparison did not show a meaningful added benefit. Nor did the longer follow-up provide a clear advantage. This is more useful than judging a product by whether it sounds soothing or whether a child’s skin happened to improve after starting it.

Eczema fluctuates. Improvement following a purchase can also reflect other care, changing symptoms or time. Random allocation helps separate those influences from the extra product being tested.

The trial was deliberately practical: families used products within everyday care rather than a highly controlled laboratory routine. That helps answer a common real-life question, while leaving some uncertainty about specific formulations and settings.

Does this mean stopping all skin care?

No. The result cannot be transferred to a leave-on moisturiser, a soap substitute or a medicine that was not the randomized question. Keep those decisions separate. If a routine is costly, confusing or difficult to maintain, discuss each component with the child’s clinician rather than abandoning the whole plan.

Current NICE guidance advises against offering emollient bath additives for childhood atopic eczema, while continuing to address leave-on care and washing advice separately. That is UK guidance, not an examination of your child or a substitute for local clinical advice.

Could a particular child still benefit?

The study explored age and bathing-frequency subgroups. Such analyses were less reliable than the main comparison, involved multiple tests and did not establish a dependable rule for choosing children or prescribing a bathing frequency.

It would be misleading to turn them into a “bathe more often” instruction. The trial was not designed to find one universal bathing schedule, and it does not answer the question for babies, adults or all climates.

Families also knew which group they were in, and symptoms were reported by parents. The study’s large practical design is a strength, but it does not make every measurement free of bias.

A simpler way to ask about an extra product

Ask what it is meant to add, what outcome was actually measured and whether the comparison kept the rest of care similar. Then ask whether the evidence applies to the person using it. These questions are more helpful than treating a long ingredient list or a medical-sounding name as proof.

For eczema, a manageable routine should still follow appropriate clinical advice. This article explains one product category; it cannot diagnose a rash, assess a flare or tell an individual family which prescribed treatment to change.

The trial was publicly funded by the UK NIHR Health Technology Assessment Programme. Authors declared no relevant financial relationships. Educational article; not clinically reviewed.

Published 11 October 2026 · Sources checked 11 October 2026. Suggest a correction.